Mycophenolate mofetil inhibits T‐cell proliferation in kidney transplant recipients without lowering intracellular dGTP and GTP
暂无分享,去创建一个
A. V. van Kuilenburg | I. T. Ten Berge | F. Bemelman | D. Back | S. Yong | J. Prins | J. Roelofsen | J. Prins | S. Sankatsing | S. Kewn | I. T. ten Berge | Sanjay U. C. Sankatsing
[1] M. Kim,et al. Mycophenolic acid inhibits cell proliferation and extracellular matrix synthesis in rat vascular smooth muscle cells through direct and indirect inhibition of cellular reactive oxygen species. , 2008, The Journal of surgical research.
[2] H. Meier‐Kriesche,et al. Calcineurin inhibitor‐free immunosuppression in kidney transplantation , 2007, Transplant international : official journal of the European Society for Organ Transplantation.
[3] K. Budde,et al. Effect of mycophenolate mofetil monotherapy on T-cell functions and inosine monophosphate dehydrogenase activity in patients undergoing a kidney transplantation. , 2006, Transplantation proceedings.
[4] D. Dunkler,et al. Activation of the Purine Salvage Pathway in Mononuclear Cells of Cardiac Recipients Treated with Mycophenolate Mofetil , 2006, Transplantation.
[5] H. Schuitemaker,et al. Short communication: No detrimental immunological effects of mycophenolate mofetil and HAART in treatment-naive acute and chronic HIV-1-infected patients. , 2005, AIDS research and human retroviruses.
[6] H. Schuitemaker,et al. Highly active antiretroviral therapy with or without mycophenolate mofetil in treatment-naive HIV-1 patients , 2004, AIDS.
[7] H. Simmonds,et al. Mycophenolate mofetil treatment following renal transplantation decreases GTP concentrations in mononuclear leucocytes. , 2004, Clinical science.
[8] S. Khoo,et al. Development of Enzymatic Assays for Quantification of Intracellular Lamivudine and Carbovir Triphosphate Levels in Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus-Infected Patients , 2002, Antimicrobial Agents and Chemotherapy.
[9] M. Yacoub,et al. ANTIVIMENTIN ANTIBODIES ARE AN INDEPENDENT PREDICTOR OF TRANSPLANT-ASSOCIATED CORONARY ARTERY DISEASE AFTER CARDIAC TRANSPLANTATION1 , 2001, Transplantation.
[10] J. Beijnen,et al. Liquid chromatographic assay for simultaneous determination of abacavir and mycophenolic acid in human plasma using dual spectrophotometric detection. , 2001, Journal of chromatography. B, Biomedical sciences and applications.
[11] A. Allison,et al. Mycophenolate mofetil and its mechanisms of action. , 2000, Immunopharmacology.
[12] J. Gummert,et al. Pharmacodynamics of immunosuppression by mycophenolic acid: inhibition of both lymphocyte proliferation and activation correlates with pharmacokinetics. , 1999, The Journal of pharmacology and experimental therapeutics.
[13] U. Heemann,et al. Mycophenolate mofetil inhibits lymphocyte binding and the upregulation of adhesion molecules in acute rejection of rat kidney allografts. , 1996, Transplant immunology.
[14] S. Yong,et al. Effects of anti‐CD3 monoclonal antibodies on functional activity of lymphocytes: studies in vivo and in vitro , 1995, Clinical and experimental immunology.
[15] Y. Natsumeda,et al. Characterization of human type I and type II IMP dehydrogenases. , 1993, The Journal of biological chemistry.
[16] A. Allison,et al. Immunosuppressive and other Effects of Mycophenolic Acid and an Ester Prodrug, Mycophenolate Mofetil , 1993, Immunological reviews.
[17] U. Andersson,et al. Effect of mycophenolate mofetil (RS-61443) on cytokine production: inhibition of superantigen-induced cytokines. , 1993, Immunopharmacology.
[18] P. K. Smith,et al. Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.
[19] M. Huang,et al. Guanine nucleotide depletion inhibits pre-ribosomal RNA synthesis and causes nucleolar disruption. , 2008, Leukemia research.
[20] J. Beijnen,et al. Effect of Mycophenolate Mofetil on the Pharmacokinetics of Antiretroviral Drugs and on Intracellular Nucleoside Triphosphate Pools , 2004, Clinical pharmacokinetics.
[21] F Miedema,et al. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). , 2000, Blood.